# NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure

> **NCT04235062** · NA · COMPLETED · sponsor: **Momentum Research, Inc.** · enrollment: 229 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Ringer's (8.6 g/L sodium chloride, 0.33 g/L calcium chloride, 0.3 g/L potassium chloride) Solution
- **DRUG:** Intravenous Bolus Furosemide

## Key facts

- **NCT ID:** NCT04235062
- **Lead sponsor:** Momentum Research, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2021-04-26
- **Final completion:** 2021-04-26
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2022-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04235062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04235062, "NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT04235062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*